← FDA Drug Approvals (Drugs@FDA)

RIBAVIRIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA · Approved 2004-10-04

Drug application

FDA Application #
ANDA076277
Application type
Abbreviated New Drug Application (Generic)
Brand name
RIBAVIRIN
Generic name
Ribavirin
Active ingredients
RIBAVIRIN
Dosage form
CAPSULE
Route
ORAL
Marketing status
Discontinued
Sponsor
TEVA
First approval
2004-10-04

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown